@mynamesabbey2's tirzepatide and IBS claims, fact-checked

Abbey's viral TikTok about life after stopping Mounjaro (tirzepatide) touches on weight maintenance and IBS symptoms, but without seeing her specific claims in detail, we're working with limited information. Here's what the science actually says about stopping this GLP-1 medication.

What happens when you stop taking tirzepatide?

Weight regain is the most documented effect when people discontinue tirzepatide. The SURMOUNT-4 trial (Aronne et al., Lancet, 2023) showed participants regained about 14% of their body weight within 17 weeks of stopping the medication after initial losses of 20.9%.

This isn't surprising. Tirzepatide works by mimicking hormones that regulate blood sugar and slow gastric emptying. When you stop, those effects disappear. Your appetite typically returns to baseline levels, and the metabolic changes reverse.

The rebound happens relatively quickly. Most people notice increased hunger within days to weeks of their last injection.

Does tirzepatide actually help with IBS symptoms?

There's no clinical trial data specifically testing tirzepatide for irritable bowel syndrome. However, the medication does cause significant gastrointestinal side effects that might mask or alter IBS symptoms while you're taking it.

In the SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022), 81.2% of participants on the 15mg dose experienced nausea, 31% had diarrhea, and 23.2% reported constipation. These effects could theoretically change someone's perception of their underlying IBS.

When people stop tirzepatide, their normal digestive patterns return. If someone had IBS before starting the medication, those symptoms would likely resume. This isn't the drug "causing" IBS, it's the underlying condition becoming apparent again.

What about long-term weight maintenance?

The research on maintaining weight loss after stopping GLP-1 medications isn't encouraging. The STEP 1 extension study followed people who achieved 14.9% weight loss on semaglutide, then stopped the medication.

Within one year of discontinuation, participants regained about two-thirds of their lost weight. Similar patterns appear in tirzepatide studies, though the data is more limited since it's a newer drug.

Some people do maintain portions of their weight loss through lifestyle changes. But the majority see significant regain without the medication's appetite-suppressing effects.

What should you know about stopping Mounjaro?

Plan for weight regain if you're considering stopping tirzepatide. This isn't a personal failure, it's how these medications work. They're designed for long-term use, not short-term weight loss followed by discontinuation.

Work with your healthcare provider on a tapering schedule rather than stopping abruptly. Some doctors recommend gradually reducing the dose over several weeks to minimize rebound effects.

If you're using tirzepatide for diabetes management, stopping could affect your blood sugar control. The SURPASS trials showed significant improvements in glycemic control that reverse when the medication is discontinued.

For more detailed information about tirzepatide's effects and proper usage, check out our comprehensive guide at /articles/glp1-hub/tirzepatide-mounjaro-guide.